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Abstract 
Background: Since the focus of healthcare has shifted toward prevention, pharmacists were highly encouraged 
to expand their practice to include immunization services. Our study aimed to assess the knowledge, attitudes and 
beliefs of community‑based Lebanese pharmacists, in addition to their willingness to expand their practice scope to 
include vaccine administration.
Methods: A cross‑sectional study was conducted during the phase preceding the arrival of the COVID‑19 vaccine in 
Lebanon between 1 and 31st December 2020. Using a stratified random sampling method, data were collected from 
Lebanese community pharmacists (CPs) through an online survey that included information on socio‑demographic 
characteristics, clinical experience, willingness to administer vaccines, knowledge about vaccination, attitudes towards 
immunization, reasons supporting utilizing pharmacists as immunizers and the requested elements to incorporate 
immunization in pharmacists’ practice scope. Multivariable analyses were performed to identify the factors associated 
with knowledge.
Results: A total of 412 community pharmacists participated in this survey. Of the total, 66.5% of the surveyed CPs are 
willing to administer vaccines. The majority of them (89.8%) had an overall good level. Out of all, 92.7% showed a posi‑
tive overall attitude score toward immunization, 95.4% agreed that community pharmacists can play an important 
role in advertising and promoting vaccination. The main needed elements for implementing immunization services 
in pharmacies listed by participants were: support of health authorities (99.3%), statutory allowance (82.8%), patient 
demand (95.4%), pharmacist’s interest (96.1%) and continuous education and training workshops on immuniza‑
tion. Older CPs (50 years and above) [aOR = 0.703, CI 95% (0.598–0.812)] and those working in Bekaa and North have 
lower knowledge score than their counterparts. High educational level [aOR = 1.891, CI 95% (1.598–2.019)], previous 
experience in immunization [aOR = 3.123, CI 95% (2.652–4.161)] and working in urban areas [aOR = 3.640, CI 95% 
(2.544–4.717)] were positively associated with a good knowledge level.
Conclusion: Most of Lebanese community pharmacists are willing to offer immunizations. The expansion of the 
pharmacists practice scope to include provision of immunizations required a national plan that encompasses 
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Introduction
Immunization is considered as one of the most cost-
effective strategy for disease prevention [1]. Despite its 
known benefits, adult immunization rates worldwide 
fall below desired targets [2]. Many factors have been 
identified as barriers towards achievement of target 
immunization coverage rates, including general public 
apathy, concerns and misconceptions about the safety 
and efficacy of vaccines, cost, lack of access to immu-
nizers and convenience [3]. Thus, in order to improve 
immunization rate, there is an urgent need to address 
these barriers.
Since the focus of healthcare has shifted toward pre-
vention, pharmacists were highly encouraged to expand 
their practice to incorporate preventive measures 
including immunization [4, 5]. Besides, one of the sug-
gested strategies to succeed in an immunization pro-
gram and increase the coverage rates among adults lies 
in involving pharmacists in vaccine administration [6]. 
This extension in the practice scope can be achieved 
through different ways such as starting by advocat-
ing immunization through raising awareness about the 
benefits of vaccine among the public, particularly phar-
macy visitors, discussing the patient’s immunization 
status and recommending vaccines during the patient’s 
visit to the pharmacy. Lastly, pharmacists, especially 
community ones, can be potential immunizers by 
administering vaccines in their practice setting [7].
In their attempt to increase the rate of immunization, 
many countries have adopted the strategy of involving 
non-traditional immunization providers and, thus, allow-
ing pharmacists to administer vaccines [8]. Many studies 
intended to highlight the positive effects of implement-
ing vaccinations in community pharmacies. The results 
of these studies showed that pharmacists increase the 
availability of vaccinations, accelerate immunization, 
effectively educate patients, affect the vaccination cov-
erage rate, prevent new cases of diseases, and by reduc-
ing the number of diseases or complications, they bring 
savings to the healthcare system [9–13]. Experiences in 
countries, who adopted the mentioned strategy such as 
England, Portugal, and the United States, prove the bene-
fits of pharmacy-driven vaccination for both patients and 
the healthcare system [14]. Similarly, in Canada, follow-
ing the implementation of vaccination administered by 
pharmacists, the proportion of people vaccinated in the 
general population has increased significantly [15].
In Lebanon, the distribution of community pharmacies 
among Lebanese province is not equitable and its own-
ership is private on a for-profit basis [16]. According to 
the Lebanese Order of Pharmacists (OPL) and the Min-
istry of Public Health (MOPH) laws, pharmacists should 
be omnipresent during the pharmacy’s opening hours. 
However, they are not permitted by law to administer 
vaccines. Their role is only restricted to dispense vaccines 
received from pharmaceutical companies. This year has 
witnessed a debate about allowing pharmacists to admin-
ister influenza vaccine as applied in other countries. Sub-
sequently, MOPH has issued a memorandum No. 149 
in October 6th 2020 to assert the restricted role of CPs 
with regard to vaccine administration. However, based 
on some observations, it is commonly found that many 
pharmacists CPs influenza vaccines to their patients 
as part of their current practices. In addition, it is well 
known that Lebanese pharmacists are actively involved 
in raising awareness and public health promotion [17]. In 
the light of COVID-19 pandemic and the need to enroll 
a national vaccination plan and prior to embarking on a 
program expanding the scope of pharmacy practice to 
include the provision of immunizations, it is important 
to understand the intention of the Lebanese pharma-
cist to become an immunization provider. Such infor-
mation highlights the importance of policy change and 
legal reform toward expanding the scope of pharmacy 
practice. Thus, our study aims to assess the knowledge, 
attitudes and beliefs of community-based Lebanese phar-
macists with respect to expanding their scope of practice, 




A cross-sectional study using an internet-based survey 
was conducted during the phase preceding the arrival of 
the COVID-19 vaccine in Lebanon between 1 and 31st 
December 2020. Pharmacists were electronically invited 
to participate. A stratified random sampling method was 
used in this survey to select a representative sample of 
CPs from the eight Lebanese provinces. The number of 
CPs selected from each province was calculated using a 
probability-proportion to size sampling method based 
on the list of CPs provided by the OPL. CPs working cur-
rently in pharmacy setting and who agreed to participate 
to the study were eligible for participation. Exclusion 
strengthening knowledge, training, certification for eligibility to administer vaccines, enhancing pharmacovigilance 
and statutory reform.
Keywords: Community pharmacists, Immunization, Willingness, Readiness, Lebanon
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criteria included: clinical pharmacists, retired CPs, those 
who were out of the country at the time of the survey, as 
well as those not practicing actually. Pharmacists who 
were unreachable due to change of their contact informa-
tion during the time of the survey and those who refused 
to participate in the study were also excluded.
Questionnaire development
A 58-item questionnaire was developed and designed 
specifically by the authors to assess the study objec-
tives and to cover important aspects of pharmacists as 
immunizers. It was drafted, piloted and modified prior 
to distribution. A panel of experts involving both rural 
and urban pharmacists provided comments on the sur-
vey design. They were asked to provide qualitative feed-
back on clarity, wording, interpretability and relevance. 
Then, the original English draft of the questionnaire was 
translated and adapted to the Arabic language based on 
standard translation guidelines [18]. The questionnaire 
was pre-tested among 30 community pharmacists for 
survey flow, functionality, readability, comprehension of 
instructions, and clarity. Based upon feedback from the 
pre-test, minor modifications regarding readability and 
clarity were made to the questionnaire. Furthermore, the 
reliability of the questionnaire was checked. The average 
time for filling the survey was 12 min. The questionnaire 
was self-administered and consisted of close-ended ques-
tions. It was divided into 6 domains:
1. Baseline information of participants:  including age, 
gender, profile, educational level, clinical experience 
and working hours in addition to information about 
the pharmacy (location, opening hours…).
2. Pharmacists’ willingness to administer adult vac-
cines.
3. Pharmacists’ knowledge about vaccination.
4. Pharmacists’ specific immunization attitudes.
5. Reasons supporting utilizing pharmacists as immu-
nizers.
6. Elements needed  to incorporate immunization in 
pharmacists’ practice scope.
Knowledge and attitude scores were computed. Partici-
pants’ overall knowledge and overall attitude were cat-
egorized using modified Bloom’s cut-off point as good if 
the score was equal or more than 60%, and poor if the 
score was less than 60%.
Sample size calculation
To calculate the sample size of the study, the Raosoft 
sample size calculator was used. Based on a total popula-
tion size of 4185 community pharmacies registered with 
OPL, a 95% confidence level and an absolute error of 
5%, a minimal sample of 352 pharmacists was required 
to allow adequate power for bivariate and multivariable 
analyses.
Data collection
An anonymous online questionnaire using a Google 
form was sent using WhatsApp or email to all commu-
nity pharmacists. Then, pharmacists were contacted via 
phone call and notified about the survey and its purpose. 
The link of the study included a brief introduction to the 
background, the objective of the survey, and instructions 
for filling the questionnaire.
Ethical considerations
A written informed consent was obtained for each par-
ticipant. They were reassured that their participation is 
voluntary and that they are free to withdraw at any time. 
In addition, all information was gathered anonymously 
and handled confidentially. The study design assured 
adequate protection of study participants, and neither 
included clinical data about patients nor configured itself 
as a clinical trial. Hence, this study was exempted from 
ethical approval of the ministry of Public Health.
Statistical analysis
The collected data were checked for completeness and 
consistency before analysis. The data were analyzed 
using the statistical software SPSS (Statistical Package for 
Social Sciences), version 22.0. A reliability analysis was 
done to validate each of these scores and was performed 
using the Cronbach’s alpha test. A coefficient of above 0.7 
indicated a good internal consistency. Descriptive sta-
tistics were reported using frequency and percentages 
for categorical variables. Finally, the analyzed data were 
organized and presented in the tabular, graphical and 
narrative form as necessary.
Results
Baseline characteristics of the study participants
Table 1 shows the baseline characteristics of the partici-
pants. A total of 412 community pharmacists partici-
pated in this survey of which 54.9% are females. Most of 
them (62.4%) are aged less than 40 years. More than half 
of them (55.1%) are pharmacy owners and 55.6% have a 
bachelor of science (BS) in pharmaceutical sciences. With 
respect to their work, 43.7% of them have a work expe-
rience of more than 10  years as community pharmacist 
and only 23.3% have no previous experience in immu-
nization. Regarding pharmacy distribution, the majority 
of pharmacists (68%) work in urban area particularly in 
Mount-Lebanon province (37.6%). Lastly, the majority 
of pharmacies where our participants work (55.30%) are 
opened 80–120 h per week.
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Willingness to be an immunizer
Of the total, 66.5% of the surveyed community pharma-
cists are willing to administer vaccines at this time, if 
they were legally permitted by the legislation to admin-
ister vaccines to adults without additional trainings. The 
willingness to incorporate this service into their prac-
tice rises to 94.4% if the legislation was combined to an 
immunization program or certification program (Figs. 1, 
2).
Pharmacists self‑reported knowledge
The majority of surveyed pharmacists (89.8%) had an 
overall good level of knowledge (≥ 60%) and only 10.2% 
of them had a poor level of knowledge (< 60%). Table  2 
illustrates the knowledge domains about vaccination. The 
majority of respondents were knowledgeable in different 
domains except the domain related to vaccine contrain-
dications and precautions. The highest knowledge scales 
were shown in the general knowledge about vaccination 
(99.3%) and the domain specific to influenza vaccination 
(90.5%). Besides, around three-quarters of respondents 
were well informed about the storage, administration and 
adverse reactions of vaccines.
Table  3 describes pharmacists’ answers to vaccination 
knowledge items. Despite the good level of knowledge 
recorded in the domain related to the storage and admin-
istration of vaccines, only 45.4% of pharmacists were 
aware that inactivated vaccines may be administered at 
Table 1 Baseline characteristics of the participants (N = 412)
N frequency, % percentage, 95% CI 95% confidence interval
n %
Gender
 Male 186 45.10%
 Female 226 54.90%
Age (years)
 20–29 128 31.10%
 30–39 129 31.30%
 40–49 81 19.70%
 Equal or more than 50 74 18.00%
Profile
 Manager 44 10.70%
 Owner 227 55.10%
 Staff pharmacist 141 34.20%
Educational level
 BS in pharmaceutical sciences 229 55.60%
 Pharm D 102 24.80%
 Master, PhD or more 81 19.70%
Years of experience
 Less than 5 years 137 33.30%
 5–10 years 95 23%
 More than 10 years 180 43.70%
Previous experience in immunization
 No 96 23.30%
 Yes 316 76.70%
Pharmacist’s working hours per week
 24 h or less 93 23.60%
 25–40 h 87 21.10%
 More than 40 h 232 56.30%
Geographic location of the pharmacy
 Rural 132 32%
 Urban 280 68%
Province
 Mount‑Lebanon 155 37.6%
 Beirut 73 17.72%
 Nabatyeh + South 94 22.8%
 Great Bekaa (Bekaa + Baalbeck‑Hermel) 42 10.2%
 Great North(North + Akkar) 48 11.65%
Number of hours/week pharmacy is open
 Less than 80 h 153 37.20%
 80–120 h 228 55.30%





Willingness to incorporate vaccination service into your 
practice/business without additional training if it is legally permitted?
Fig. 1 At this time, if you were legally permitted by the legislation 
to administer vaccines to adults, are you willing to incorporate this 





Willingness to incorporate vaccination service into practice after 
attending  an immunization training or certification program and 
being legally permitted
Fig. 2 If an immunization training or certification program was 
available to you, and you were legally permitted by the legislation 
to administer vaccines to adults, are you willing to incorporate this 
service into your practice/business?
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the same time or at any time before or after a live vaccine. 
Similarly, 45.4% of them were not knowledgeable about 
the fact that local adverse reaction such as pain, swell-
ing, and redness at the injection site generally occurred 
within few hours of the injection, and are usually mild 
and self-limited.
In respect of the contraindications and precautions 
domains of vaccine, only 26% of participants considered 
that pneumococcal vaccination is not contraindicated for 
asplenic patients.
Pharmacists’ specific immunization attitudes
Out of all, 92.7% of surveyed pharmacists showed a posi-
tive overall attitude score toward immunization. Around 
90% of them considered that vaccines produce more 
health benefits than health risks, and that increasing the 
proportion of adults who receive recommended immuni-
zations is important. However, only 20.4% of them con-
sidered that natural infection or a healthy lifestyle are 
effective alternatives to vaccines.
Reasons supporting utilizing pharmacists as immunizers
The majority of respondents (95.4%) agreed that com-
munity pharmacists can play an important role in adver-
tising and promoting vaccination. Moreover, more than 
90% of them considered that allowing pharmacists to 
vaccinate can reduce costs paid by patients, and that 
pharmacies are easily accessible to the community which 
will improve the overall vaccination rate among adults as 
they feel more comfortable. In addition, 84.7% of them 
agreed that pharmacists should be legally permitted to 
administer vaccines. However, only 50% of respondents 
agreed that pharmacists have received adequate teach-
ing/training about vaccine administration during their 
education (Fig. 3).
Elements needed for implementing immunization services 
in pharmacies
The main needed elements for implementing immuniza-
tion services in pharmacies listed by participants were: 
support of health authorities (Ministry of Public Health 
and Order of Lebanese Pharmacists) (99.3%), statutory 
allowance (82.8%), patient demand (95.4%), pharmacist’s 
interest (96.1%) and continuous education and training 
workshops on immunization, safe administration and 
handling of vaccines (93.7%). Only 55.6% of participated 
pharmacists highlighted the need of formal certification 
in vaccine administration as requisite for allowing phar-
macists to be immunizers (Table 4).
Factors associated with good knowledge among CPs
Table 5 displays the factors associated with good knowl-
edge score among CPs. Older CPs aged 50  years and 
above [aOR = 0.703, 95% CI (0.598–0.812)] were less 
knowledgeable than younger CPs aged between 20 
and 39  years old. CPs with higher education level than 
BS in pharmaceutical sciences [aOR = 1.891, CI 95% 
(1.598–2.019)] and previous experience in immunization 
[aOR = 3.123, CI 95% (2.652–4.161)] were more likely 
to have a good knowledge score than those who have 
a BS degree in pharmaceutical sciences and who lack 
from previous experience in immunization. CPs work-
ing in pharmacies located in urban areas [aOR = 3.640, 
CI 95% (2.544–4.717)] showed better level of knowl-
edge than their counterparts working in rural areas. Our 
findings showed also that CPs working in Great Bekaa 
[aOR = 0.703, CI 95% (0.598–0.812)] and great North 
have lower odds of good knowledge than those working 
in Beirut.
Discussion
This study was conducted during the preparedness phase 
for the roll-out of COVID-19 vaccines in Lebanon. It 
has particular importance during the COVID-19 pan-
demic as pharmacists could have a responsibility to take a 
prominent role in combating infectious diseases and con-
trol programs in health-care systems, in addition to their 
significant impact on the vaccination coverage rate. To 
the best of our knowledge, this is the first representative 
national Lebanese study aiming to explore readiness and 
Table 2 Pharmacist’s knowledge domains
Poor Good
n (%) n (%)
D1 Domain 1: General knowledge 3 (0.7%) 409 (99.3%)
D2 Domain 2: Influenza vaccines 39 (9.5%) 373 (90.5%)
D3 Domain 3: Contraindications and precautions to vaccination 284 (68.9%) 128 (31.1%)
D4 Domain 4: Storage and administration of vaccine 114 (27.7%) 298 (72.3%)
D5 Domain 5: Adverse reactions following vaccination 102 (24.8%) 310 (75.2%)
Overall knowledge 42 (10.2%) 370 (89.8%)
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Table 3 Pharmacists’ answers to knowledge items
# Correct Incorrect I don’t Know
n (%) n (%) n (%)
D1: General knowledge
 K1 Vaccines are critical to the prevention and control of infectious diseases outbreaks 409 (99.3%) 3 (0.7%) 0 (0%)
 K2 The ingredients of the vaccine include: the antigen, adjuvants, preservatives, and stabilizers 375 (91%) 6 (1.5%) 31 (7.5%)
 K3 Vaccines are safe and serious problems from the vaccine are very rare 383 (93%) 20 (7%) 9 (2.2%)
 K4 Every vaccine must go through extensive and rigorous testing before it can be introduced 402 (97.6%) 6 (1.4%) 4 (1%)
 K5 During the COVID‑19 pandemic, vaccination continues to be critically important 396 (96.1%) 6 (1.4%) 10 (2.5%)
 K6 Vaccines reduce the risks of getting a disease by working with the body’s natural defenses to build 
protection
412 (100%) 0 (0%) 0 (0%)
 K7 Not all vaccinations may be needed in Lebanon, some may only be given prior to travel, or to 
people in high‑risk
334 (81.1%) 78 (18.9%) 4 (1%)
 K8 Following the introduction of a vaccine, close monitoring continues to detect any unexpected 
adverse side effects and assess the effectiveness
377 (91.5%) 22 (5.3%) 13 (3.2%)
 K9 Vaccines protect us throughout life and at different ages, from birth to childhood, as teenagers, and 
into old age
378 (91.7%) 28 (6.8%) 6 (1.5%)
D2: Influenza vaccination
 K10 Unvaccinated people with mild symptoms of influenza can spread the disease to others 383 (93%) 22 (5.3%) 7 (1.7%)
 K11 The seasonal flu vaccine protects against the most common influenza viruses including H1N1 358 (86.9%) 38 (9.2%) 16 (3.9%)
 K12 Annual influenza immunization is recommended for all health‑care professionals in contact with 
individuals in high‑risk groups
404 (98.1%) 8 (1.9%) 0 (0%)
 K13 Anyone can get very sick from influenza, including people who are healthy 334 (81.1%) 66 (16%) 12 (2.9%)
D3: Contraindications and precautions to vaccination
 K14 Pneumococcal vaccination is contraindicated for asplenic (without a spleen) patients 107 (26%) 103 (25%) 202 (49%)
 K15 Breastfeeding is a contraindication to vaccination 292 (70.9%) 47 (11.3%) 73 (17.8%)
 K16 Pregnant women who are expected to deliver during the influenza season should not receive the 
influenza vaccine
300 (72.8%) 56 (13.6%) 56 (13.6%)
 K17 Anaphylactic reaction to a previous dose of vaccine or a vaccine component is a contraindication to 
further doses of the same vaccine or to the same component in other vaccines
387 (93.9%) 7 (1.5%) 18 (4.4%)
 K18 Persons receiving immunosuppressive medications should not receive the influenza vaccine 204 (49.5%) 134 (32.5%) 74 (18%)
 K19 Live‑virus vaccines (MMRII…) should be postponed until after chemotherapy or high‑dose steroid 
has ended
342 (83%) 25 (6.3%) 45 (10.7%)
D4: Storage and administration of vaccine
 K20 Improper storage of vaccines may affect the immune response of the vaccine recipient 384 (93.2%) 7 (1.7%) 21 (5.1%)
 K21 Stabilizers protect the vaccine during storage and transportation 356 (86.4%) 26 (6.3%) 30 (7.3%)
 K22 Inactivated vaccines may be administrated at the same time or at any time before or after a live 
vaccine
187 (45.4%) 112 (27.2%) 113 (27.4%)
 K23 A person who received a live vaccine should wait 28 days before receiving another live vaccine 291 (70.6%) 48 (11.7%) 73 (17.7%)
D5: Adverse reactions following vaccination
 K24 Local adverse reaction such as pain, swelling, and redness at the injection site generally occurred 
within a few hours of the injection and are usually mild and self‑limited
187 (45.4%) 219 (53.1%) 6 (1.5%)
 K25 Systemic adverse reactions may occur following receipt of live, attenuated vaccines which must 
replicate to produce immunity
283 (68.7%) 85 (20.6%) 44 (10.7%)
 K26 A systemic reaction is usually mild and occurs 3–21 days after the vaccine was administrated (incu‑
bation period of the vaccine)
318 (77.2%) 23 (5.5%) 71 (17.2%)
 K27 Severe allergic reactions may be life‑threatening but fortunately, they are rare 386 (93.7%) 10 (2.4%) 16 (3.9%)
 K28 The risk of an allergic reaction can be decreased by effective screening prior to vaccination 316 (76.7%) 43 (10.5%) 53 (12.8%)
 K29 Providers should report any clinically significant adverse event occurring after administration of the 
vaccine even if they are unsure whether the vaccine caused the event
400 (97.1%) 3 (0.7%) 9 (2.2%)
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willingness of community pharmacists to expand their 
practice scope into administering vaccines for adults.
The main findings in our study were that more than 
half of the surveyed community pharmacists are willing 
to start in the meantime the administration of vaccines 
in case they were legally permitted to do it without 
additional training. However, this willingness to incor-
porate this service into their practice rises to more than 
90% if the legislation was combined to an education or 
certification program. This could be explained by the 
fact that despite their willingness to proceed, many 
pharmacists felt not well prepared, given that their 
education was not sufficient to begin at this time incor-
porating immunization services at their practice, and 
that formal certification should be required to do so. In 
this context, many pharmacist regulatory bodies have 
recognized the stipulation of proper immunization 









0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Community pharmacists received adequate teaching/training
about vaccine administration during their pharmacy training.
Pharmacists have good knowledge of vaccines and their
indications and contraindications
If pharmacists were permitted to immunize, most adults would
feel comfortable receiving their recommended vaccinations
from a pharmacist.
Pharmacists should be permitted to expand their practice to
include the administration of recommended adult vaccines.
Providing vaccination through community pharmacy will
improve the overall rate of vaccination among adults
Community pharmacists are easily accessible to the community
(hours of availability, geographical distribution....)
Allowing pharmacists to vaccinate can reduce costs of
vaccination paid by patients
Community pharmacists can play an important role in
advertising and promoting  vaccination
% of agreement
Fig. 3 Reasons supporting utilizing pharmacists as immunizers as perceived by CPs
Table 4 Elements needed for implementing immunization services in pharmacies
No Yes
n (%) n (%)
E1 More university education and training on immunization administration for pharmacists are needed 67 (16.3%) 345 (83.7%)
E2 Formal certification in vaccine administration should be required for pharmacists 183 (44.4%) 229 (55.6%)
E3 Continuous education and training workshops on immunization, safely administration and handling of vaccines 26 (6.3%) 386 (93.7%)
E4 Financial reimbursement or adequate remuneration 66 (16%) 346 (84%)
E5 Patients demand 19 (4.6%) 393 (95.4%)
E6 Collaboration with medical clinics 86 (20.9%) 326 (79.1%)
E7 Support from medical and nursing associations 76 (18.4%) 336 (81.6%)
E8 Support of health authorities (Ministry of Public Health and Order of Lebanese Pharmacists) 3 (0.7%) 409 (99.3%)
E9 Pharmacist interest 16 (3.9%) 396 (96.1%)
E10 Legal issue 71 (17.2%) 341 (82.8%)
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developing immunization training programs to ensure 
safe and effective administration of vaccines by phar-
macists [19]. Such programs show their success in the 
Maritimes, in which 97% of pharmacists felt prepared 
to administer immunizations following completion [2].
In regard to community pharmacists’ knowledge, 
our results showed that the majority of respondents 
were knowledgeable in different domains except the 
domain related to vaccine contraindications and precau-
tions. Good knowledge is crucial to expand the scope of 
Table 5 Multivariable logistic regression of the factors associated with knowledge of CPs
N frequency, % percentage, aOR adjusted odds ratio, 95% CI 95% confidence interval
Overall knowledge P‑value aOR CI 95%
Poor Good
n (%) n (%) Lower Upper
Gender 0.089
 Male 16 (38.1%) 170 (61.9%)
 Female 26 (11.5%) 200 (88.5%)
Age (years) 0.023
 20–39 15 (5.8%) 242 (94.2%) Ref
 40–49 6 (7.5%) 75 (92.5%) 0.143 0.813 0.765 1.354
 50–59 9 (16.9%) 44 (83.1%) 0.038 0.703 0.598 0.812
 Equal or more than 60 12 (57.1%) 9 (42.9%) 0.021 0.604 0.478 0.756
Profile 0.207
 Manager 10 (22.7%) 34 (77.3%)
 Staff pharmacist 20 (14.2%) 121 (85.8%)
 Owner 12 (5.6%) 215 (94.4%)
Educational level 0.012
 BS in pharmaceutical sciences 29(12.7%) 200 (87.3%) Ref
 More than BS 13(7.1%) 170 (92.9%) 0.039 1.891 1.598 2.019
Years of experience 0.106
 < 5 years 20 (14.6%) 117 (85.4%)
 5–10 years 13(13.7%) 82 (86.3%)
 More than 10 years 9(5%) 171 (95%)
Previous experience in immunization 0.008
 No 29 (30.2%) 67 (69.8%) Ref
 Yes 13 (4.1%) 303 (95.9%)  < 0.001 3.123 2.652 4.161
Geographic location of the pharmacy  < 0.001
 Rural 32 (24.2%) 100 (75.6%) Ref
 Urban 10 (3.6%) 270 (96.4%) < 0.001 3.64 2.544 4.717
Province (pharmacy) 0.045
 Mount‑Lebanon 7 (4.5%) 148 (95.5%) Ref
 Beirut 4 (5.5%) 69 (94.5%) 0.165 0.815 0.712 1.103
 Nabatyeh + South 6 (6.4%) 88 (93.6%) 0.112 0.693 0.567 1.012
 Great Bekaa(Baalbeck‑Hermel + Bekaa) 11 (26.2%) 31 (73.8%) 0.041 0.185 0.112 0.223
 Great North(Akkar + North) 14 (29.2%) 34 (70.8%) 0.029 0.198 0.143 0.318
Number of hours/week pharmacy is open 0.131
 Less than 50 h 5 (27.8%) 13 (72.2%)
 50–120 h 29 (8%) 340 (92%)
 7 days 24/24 8 (25.8%) 23 (74.2%)
Pharmacist’s working hours per week 0.148
 Less than 40 h 10 (10.7%) 83 (89.3%)
 More than 40 h 32 (10%) 287 (90%)
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practice of pharmacists as it supports them in provid-
ing adequate education to the public and, consequently, 
improving their performance and confidence in admin-
istrating vaccines. However, this study indicates that 
respondents lack the necessary knowledge of precautions 
and contraindications of vaccines, and those related to its 
administration such as the possibility of administration 
of inactivated vaccines at the same time or at any time 
before or after a live vaccine. Also, knowledge regarding 
the fact that local adverse reaction occurring at the injec-
tion site within few hours of administration and that are 
usually mild and self-limited, was not well recognized. 
These gaps in knowledge may need to be narrowed and 
underline a crucial need for strategies to educate com-
munity pharmacists about particular aspects of the 
contraindications and precautions of vaccines through 
continuing medical education, supplementary profes-
sional information, and additional patient educational 
materials [20]. It should be noted that a good proportion 
of the participants recognized the need for further edu-
cation in this field.
It is notable that our results proved positive attitude 
toward utilization of pharmacists as immunizers. Most 
of pharmacists appraised the importance of their role in 
advertising and promoting vaccination among public. 
This is consistent with the findings of a study conducted 
in Italy that investigated KAP regarding vaccinations by 
community pharmacists in Italy [21]. Moreover, pharma-
cists believed that allowing them to vaccinate can reduce 
costs paid by patients and that pharmacies are easily 
accessible to the community which will improve the over-
all vaccination rate among adults as they feel more com-
fortable. Our results aligned with the findings of many 
studies that showed that vaccination costs were less when 
this service was provided by pharmacists, compared to 
those that were physician-administered [22]. Another 
study showed that immunization rates against influenza 
were higher for individuals aged more than years old in 
areas where pharmacists provided vaccinations, most 
likely due to improved accessibility and convenience [23, 
24]. Finally, increased vaccination rate will be translated 
by a decrease in mortality and hospitalizations rates in 
elderly patients; hence, reduction of the cost related to 
direct medical care [25, 26].
In addition, 84.7% of pharmacists agreed that they 
should be legally permitted to administer vaccines. This 
highlights the importance to focus on statutory reform 
to enable pharmacists to provide vaccination under the 
umbrella of law [27].
Since only half of respondents agreed that pharma-
cists have received adequate teaching/training about 
vaccine administration during their education, addi-
tional training for proper immunization practices is 
highly recommended. This should be synchronized 
with regulation changes anticipated by the profession 
and pharmacy schools to expand the scope of practice 
and enable pharmacist-administered vaccination.
Regarding the factors necessary for the implementa-
tion of vaccination services in community pharmacies, 
participants indicated that support of health authorities 
(Ministry of Public Health and Order of Lebanese Phar-
macists), statutory allowance, patient demand, phar-
macist interest and continuous education and training 
workshops on immunization, safe administration and 
handling of vaccines are needed. Consistently, many 
studies found similar results with respect to essential 
elements identified, such as legal liability and formal 
education [28, 29]. With respect to patient demand, 
CDC estimates that almost 20% of the 2010–2011 influ-
enza adult vaccinations were administered by pharma-
cists [30].
In terms of factors associated with CPs’ good knowl-
edge, our findings showed that CPs with older age, and 
working in pharmacies in Bekaa and North have lower 
knowledge score than their counterparts. However, 
CPs with high educational level, previous experience in 
immunization and working in urban areas showed higher 
tendency to have good knowledge level. Our results were 
comparable to the findings of a study conducted in Italy 
that revealed that higher level of knowledge was reported 
among younger CPs and those with a lower number of 
years since degree [21]. The role of higher education in 
predicting better vaccination knowledge might be due 
that they have more opportunities to learn and receive 
adequate education and training through their university 
pharmacy curricula. Given that CPs can be a key point 
of contact for patients especially who live in rural areas, 
our findings highlighted the importance of improving the 
knowledge of the CPs who worked in such areas.
Continuous education and training workshops on 
immunization, safe administration and handling of vac-
cines are recommended in addition to the formal certifi-
cation in vaccine administration as requisite for allowing 
pharmacists to be immunizers. Vaccine adverse event 
reporting systems are essential to ensure vaccine safety 
and surveillance, and maintain people’s confidence in 
vaccines. There is need to establish immunization records 
which allow pharmacists to identify missed vaccinations, 
offer reminders to patients, and update immunization 
records to improve reporting of immunization cover-
age. Further integration of such systems and procedures 
across healthcare providers are needed for pharmacists 
to be incorporated in the overall health system to present 
a united front in offering vaccination services. Lastly, it is 
necessary to prepare standards as well as a legal frame-
work for the provision of such services.
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Limitations of the study
Some limitations of this study should be acknowledged. 
First, the cross-sectional design of this study does not 
allow us to infer causality. Second, our study relies on 
community pharmacists’ self-reported information, 
which makes it prone to the disadvantages of desirabil-
ity biases. Furthermore, this online questionnaire might 
have favored a selection bias since it might only allow 
the participation of community pharmacists who have 
access to online resources. Lastly, recall bias could have 
occurred particularly for the questions related to past 
behavior.
Conclusion
Most of Lebanese community pharmacists are willing 
to offer immunizations. Thus, the expansion of CPs 
scope of practice to include the provision of vaccine 
required the implementation of a national plan. This 
plan can encompass the following pillars that should 
be incorporated in parallel: strengthening knowledge 
and education about the topic for graduated pharma-
cist, incorporating vaccines and immunization in the 
academic curricula, offering post-graduate certificate 
and diploma for eligibility to administer vaccines with 
periodic re-certification, enhancing the role of phar-
macovigilance and reporting within this scope and, 
statutory reform. Future studies are needed to examine 
pharmacists’ perceived barriers about immunization, as 
well as the determinants of their willingness to admin-
ister vaccines.
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